Markets:

Overview

News

Currencies

International

Treasuries

Codexis, Inc. - Common Stock (NQ:CDXS)

1.430 -0.170 (-10.63%)

Streaming Delayed Price Updated: 10:38 AM EDT, Mar 23, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about Codexis, Inc. - Common Stock

< Previous 1 2 3 4 Next >

Which stocks are moving on Thursday? ↗

March 12, 2026

Via Chartmill

Gapping stocks in Thursday's session ↗

March 12, 2026

Via Chartmill

Discover the top movers in Thursday's pre-market session. ↗

March 12, 2026

Via Chartmill

Codexis (CDXS) Q4 2025 Earnings Call Transcript ↗

March 11, 2026

Codexis (CDXS) Q4 2025 Earnings Call Transcript

Via The Motley Fool

Topics Earnings

CODEXIS INC (NASDAQ:CDXS) Stock Surges 40% on Strong Q4 Earnings Beat ↗

March 11, 2026

Via Chartmill

Earnings Scheduled For November 6, 2025 ↗

November 06, 2025

Via Benzinga

A Look at Codexis's Upcoming Earnings Report ↗

August 12, 2025

Via Benzinga

Top movers in Wednesday's after hours session ↗

March 11, 2026

Via Chartmill

Why Did CDXS Stock Jump 7% Today? ↗

March 04, 2026

The company tied up with an innovator pharmaceutical company to manufacture 50 grams of small interfering RNA using a proprietary ECO Synthesis platform.

Via Stocktwits

12 Health Care Stocks Moving In Friday's After-Market Session ↗

November 07, 2025

Via Benzinga

12 Health Care Stocks Moving In Friday's Pre-Market Session ↗

November 07, 2025

Via Benzinga

Preview: Codexis's Earnings ↗

May 13, 2025

Via Benzinga

Earnings Scheduled For February 27, 2025 ↗

February 27, 2025

Via Benzinga

Deep Dive Into Codexis Stock: Analyst Perspectives (4 Ratings) ↗

November 22, 2024

Via Benzinga

Codexis Inc (NASDAQ:CDXS) Plummets After Q3 2025 Revenue and Earnings Miss ↗

November 06, 2025

Codexis stock plunges after Q3 2025 earnings miss estimates, with revenue of $8.6M falling far short of expectations.

Via Chartmill

Topics Earnings

What's going on in today's after hours session ↗

November 06, 2025

Discover the top movers in Thursday's after-hours session and stay informed about the post-market dynamics.

Via Chartmill

12 Health Care Stocks Moving In Thursday's Pre-Market Session ↗

August 14, 2025

Via Benzinga

Codexis Revenue Jumps 91 Percent in Q2 ↗

August 13, 2025

Via The Motley Fool

12 Health Care Stocks Moving In Wednesday's After-Market Session ↗

August 13, 2025

Via Benzinga

Curious about the stocks that are showing activity after the closing bell on Wednesday? ↗

August 13, 2025

After the closing bell on Wednesday, let's take a glimpse of the US markets and explore the top gainers and losers in today's after-hours session.

Via Chartmill

Codexis Inc (NASDAQ:CDXS) Surpasses Q2 2025 Earnings Expectations with Strong Revenue and EPS Beat ↗

August 13, 2025

Codexis Inc (CDXS) beat Q2 2025 revenue and EPS estimates, driving a 6.89% after-hours stock surge. Strong enzyme engineering and RNAi therapeutic progress fuel optimism.

Via Chartmill

12 Health Care Stocks Moving In Wednesday's Pre-Market Session ↗

August 13, 2025

Via Benzinga

Earnings Scheduled For August 13, 2025 ↗

August 13, 2025

Via Benzinga

12 Health Care Stocks Moving In Thursday's After-Market Session ↗

July 10, 2025

Via Benzinga

Get insights into the top gainers and losers of Wednesday's after-hours session. ↗

May 28, 2025

As the regular session of the US market on Wednesday comes to an end, let's delve into the after-hours session and discover the top gainers and losers shaping the post-market sentiment.

Via Chartmill

12 Health Care Stocks Moving In Wednesday's After-Market Session ↗

May 14, 2025

Via Benzinga

Artiva Biotherapeutics Appoints Alison Moore, Ph.D., to Its Board of Directors

October 22, 2024

From Artiva Biotherapeutics, Inc.

Via GlobeNewswire

Earnings Scheduled For May 14, 2025 ↗

May 14, 2025

Via Benzinga

CDXS Stock Earnings: Codexis Misses EPS, Beats Revenue for Q2 2024 ↗

August 08, 2024

CDXS stock results show that Codexis missed analyst estimates for earnings per share but beat on revenue for the second quarter of 2024.

Via InvestorPlace

CDXS Stock Earnings: Codexis Beats EPS, Beats Revenue for Q1 2024 ↗

May 02, 2024

CDXS stock results show that Codexis beat analyst estimates for earnings per share and beat on revenue for the first quarter of 2024.

Via InvestorPlace

< Previous 1 2 3 4 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.